Squarepoint
SIOX

Squarepoint’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Squarepoint’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-42,388
Closed -$118K – 3787
2020
Q4 		$118K Buy
+42,388
New +$123K ﹤0.01% 2683
2020
Q3 		– Sell
-29,876
Closed -$84K – 2957
2020
Q2 		$84K Buy
+29,876
New +$95.8K ﹤0.01% 2040
2018
Q4 		– Sell
-1,392
Closed -$27K – 2326
2018
Q3 		$27K Buy
+1,392
New +$25.3K ﹤0.01% 1937
2018
Q1 		– Sell
-11,825
Closed -$499K – 2286
2017
Q4 		$499K Buy
+11,825
New +$531K 0.01% 1213
2017
Q3 		– Sell
-3,319
Closed -$616K – 1961
2017
Q2 		$616K Buy
+3,319
New +$582K 0.01% 884

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Squarepoint's SIOX Position: Q1 2021 in Review

Squarepoint sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2021, closing a stake of 42,388 shares — an estimated $118K sold.

Squarepoint first reported a position in SIOX in Q2 2017 and held it in 5 quarters. The position peaked at $616K in Q2 2017. 56 funds tracked by Wall St. Rank hold SIOX as of Q1 2021.

  • Squarepoint reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Squarepoint sold 42,388 Sio Gene Therapies Inc. Common Stock shares in Q1 2021, an estimated $118K.
  • Squarepoint first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2017 and held it in 5 quarters.
  • Squarepoint's Sio Gene Therapies Inc. Common Stock position peaked at $616K in Q2 2017.
  • 56 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.